0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Banking and Blood Products Market Research Report 2026
Published Date: 2026-03-03
|
Report Code: QYRE-Auto-31X6713
Home | Market Reports | Health| Pharmacy
China Blood Banking and Blood Products Market Report Forecast 2021 2027
BUY CHAPTERS

Global Blood Banking and Blood Products Market Research Report 2026

Code: QYRE-Auto-31X6713
Report
2026-03-03
Pages:173
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blood Banking and Blood Products Market Size

The global Blood Banking and Blood Products market was valued at US$ 60960 million in 2025 and is anticipated to reach US$ 97560 million by 2032, at a CAGR of 7.0% from 2026 to 2032.

Blood Banking and Blood Products Market

Blood Banking and Blood Products Market

Blood banking is the process that takes place in the lab to make sure that donated blood, or blood products, are safe before they are used in blood transfusions and other medical procedures. Blood banking includes typing the blood for transfusion and testing for infectious diseases. A blood product is any therapeutic substance prepared from human blood. This includes: whole blood; blood components; and plasma derivatives. Whole blood is not commonly used in transfusion medicine.
Blood products refer to various human plasma protein products, including albumin, immunoglobulin, coagulation factors, etc. The raw material of blood products is plasma. 92% - 93% of human plasma is water, and only 7% - 8% is protein. Blood products are made by separating and purifying this part of protein.
The primary driver of the blood banking market is the increasing prevalence of chronic diseases and the rising number of surgical procedures globally. Conditions such as cancer, anemia, and trauma often require blood transfusions, boosting the demand for blood and blood products. Additionally, advancements in medical technology, such as improved blood preservation techniques and the development of blood substitutes, have enhanced the efficiency of blood banking systems, further contributing to market growth. One major challenge in the blood banking market is the risk of blood contamination and the transmission of infectious diseases. Despite stringent screening processes, there remains a possibility of contamination, especially in regions with less advanced healthcare systems. Furthermore, the high cost of blood testing and the maintenance of blood banks, coupled with the difficulty in ensuring a consistent blood supply due to low donation rates in some areas, presents significant obstacles to market expansion.
The growing prevalence of immunodeficiency disorders, hemophilia, and other chronic diseases that require plasma-derived therapies is a key driver of the blood product market. Blood products, such as immunoglobulins, clotting factors, and albumin, are essential in treating conditions where patients have compromised immune systems or bleeding disorders. Furthermore, the increasing use of plasma products in emergency care and surgical procedures, along with advancements in fractionation technologies, is boosting market demand. A major challenge in the blood product market is the high cost and complexity of the plasma collection and fractionation process. The production of blood products requires strict regulatory compliance and advanced facilities to ensure the purity and safety of these therapies, driving up costs. Additionally, fluctuations in plasma donation rates and the need for extensive screening to prevent contamination or the spread of infectious diseases can lead to supply shortages, especially in regions with underdeveloped healthcare infrastructure.
This report delivers a comprehensive overview of the global Blood Banking and Blood Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Blood Banking and Blood Products. The Blood Banking and Blood Products market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Blood Banking and Blood Products market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Blood Banking and Blood Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Blood Banking and Blood Products Market Report

Report Metric Details
Report Name Blood Banking and Blood Products Market
Accounted market size in 2025 US$ 60960 million
Forecasted market size in 2032 US$ 97560 million
CAGR 7.0%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • RBCs
  • Plts
  • Plasma
  • Whole Blood
  • Plasma Fractionation Products
Segment by Application
  • Hospital
  • Clinic
  • Retail Pharmacy
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company America’s Blood Centers, Japan Red Cross Society, American Red Cross, Australia Red Cross, Red Cross Society of China, NHS Blood and Transplant, New York Blood Center, Canadian Blood Services, Sanquin Blood Supply Foundation, Blood Bank of Alaska, Vitalant, National Blood Transfusion Council, Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Blood Banking and Blood Products companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Blood Banking and Blood Products Market growing?

Ans: The Blood Banking and Blood Products Market witnessing a CAGR of 7.0% during the forecast period 2026-2032.

What is the Blood Banking and Blood Products Market size in 2032?

Ans: The Blood Banking and Blood Products Market size in 2032 will be US$ 97560 million.

Who are the main players in the Blood Banking and Blood Products Market report?

Ans: The main players in the Blood Banking and Blood Products Market are America’s Blood Centers, Japan Red Cross Society, American Red Cross, Australia Red Cross, Red Cross Society of China, NHS Blood and Transplant, New York Blood Center, Canadian Blood Services, Sanquin Blood Supply Foundation, Blood Bank of Alaska, Vitalant, National Blood Transfusion Council, Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang, Weiguang Bio, Nanyue Bio, KM Biologics

What are the Application segmentation covered in the Blood Banking and Blood Products Market report?

Ans: The Applications covered in the Blood Banking and Blood Products Market report are Hospital, Clinic, Retail Pharmacy, Others

What are the Type segmentation covered in the Blood Banking and Blood Products Market report?

Ans: The Types covered in the Blood Banking and Blood Products Market report are RBCs, Plts, Plasma, Whole Blood, Plasma Fractionation Products

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Banking and Blood Products Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 RBCs
1.2.3 Plts
1.2.4 Plasma
1.2.5 Whole Blood
1.2.6 Plasma Fractionation Products
1.3 Market by Application
1.3.1 Global Blood Banking and Blood Products Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Retail Pharmacy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Banking and Blood Products Market Perspective (2021–2032)
2.2 Global Blood Banking and Blood Products Growth Trends by Region
2.2.1 Global Blood Banking and Blood Products Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Blood Banking and Blood Products Historic Market Size by Region (2021–2026)
2.2.3 Blood Banking and Blood Products Forecasted Market Size by Region (2027–2032)
2.3 Blood Banking and Blood Products Market Dynamics
2.3.1 Blood Banking and Blood Products Industry Trends
2.3.2 Blood Banking and Blood Products Market Drivers
2.3.3 Blood Banking and Blood Products Market Challenges
2.3.4 Blood Banking and Blood Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Banking and Blood Products Players by Revenue
3.1.1 Global Top Blood Banking and Blood Products Players by Revenue (2021–2026)
3.1.2 Global Blood Banking and Blood Products Revenue Market Share by Players (2021–2026)
3.2 Global Top Blood Banking and Blood Products Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Blood Banking and Blood Products Revenue
3.4 Global Blood Banking and Blood Products Market Concentration Ratio
3.4.1 Global Blood Banking and Blood Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Banking and Blood Products Revenue in 2025
3.5 Global Key Players of Blood Banking and Blood Products Head Offices and Areas Served
3.6 Global Key Players of Blood Banking and Blood Products, Products and Applications
3.7 Global Key Players of Blood Banking and Blood Products, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Blood Banking and Blood Products Breakdown Data by Type
4.1 Global Blood Banking and Blood Products Historic Market Size by Type (2021–2026)
4.2 Global Blood Banking and Blood Products Forecasted Market Size by Type (2027–2032)
5 Blood Banking and Blood Products Breakdown Data by Application
5.1 Global Blood Banking and Blood Products Historic Market Size by Application (2021–2026)
5.2 Global Blood Banking and Blood Products Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Blood Banking and Blood Products Market Size (2021–2032)
6.2 North America Blood Banking and Blood Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Blood Banking and Blood Products Market Size by Country (2021–2026)
6.4 North America Blood Banking and Blood Products Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Banking and Blood Products Market Size (2021–2032)
7.2 Europe Blood Banking and Blood Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Blood Banking and Blood Products Market Size by Country (2021–2026)
7.4 Europe Blood Banking and Blood Products Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Blood Banking and Blood Products Market Size (2021–2032)
8.2 Asia-Pacific Blood Banking and Blood Products Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Blood Banking and Blood Products Market Size by Region (2021–2026)
8.4 Asia-Pacific Blood Banking and Blood Products Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Blood Banking and Blood Products Market Size (2021–2032)
9.2 Latin America Blood Banking and Blood Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Blood Banking and Blood Products Market Size by Country (2021–2026)
9.4 Latin America Blood Banking and Blood Products Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Banking and Blood Products Market Size (2021–2032)
10.2 Middle East & Africa Blood Banking and Blood Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Blood Banking and Blood Products Market Size by Country (2021–2026)
10.4 Middle East & Africa Blood Banking and Blood Products Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 America’s Blood Centers
11.1.1 America’s Blood Centers Company Details
11.1.2 America’s Blood Centers Business Overview
11.1.3 America’s Blood Centers Blood Banking and Blood Products Introduction
11.1.4 America’s Blood Centers Revenue in Blood Banking and Blood Products Business (2021–2026)
11.1.5 America’s Blood Centers Recent Development
11.2 Japan Red Cross Society
11.2.1 Japan Red Cross Society Company Details
11.2.2 Japan Red Cross Society Business Overview
11.2.3 Japan Red Cross Society Blood Banking and Blood Products Introduction
11.2.4 Japan Red Cross Society Revenue in Blood Banking and Blood Products Business (2021–2026)
11.2.5 Japan Red Cross Society Recent Development
11.3 American Red Cross
11.3.1 American Red Cross Company Details
11.3.2 American Red Cross Business Overview
11.3.3 American Red Cross Blood Banking and Blood Products Introduction
11.3.4 American Red Cross Revenue in Blood Banking and Blood Products Business (2021–2026)
11.3.5 American Red Cross Recent Development
11.4 Australia Red Cross
11.4.1 Australia Red Cross Company Details
11.4.2 Australia Red Cross Business Overview
11.4.3 Australia Red Cross Blood Banking and Blood Products Introduction
11.4.4 Australia Red Cross Revenue in Blood Banking and Blood Products Business (2021–2026)
11.4.5 Australia Red Cross Recent Development
11.5 Red Cross Society of China
11.5.1 Red Cross Society of China Company Details
11.5.2 Red Cross Society of China Business Overview
11.5.3 Red Cross Society of China Blood Banking and Blood Products Introduction
11.5.4 Red Cross Society of China Revenue in Blood Banking and Blood Products Business (2021–2026)
11.5.5 Red Cross Society of China Recent Development
11.6 NHS Blood and Transplant
11.6.1 NHS Blood and Transplant Company Details
11.6.2 NHS Blood and Transplant Business Overview
11.6.3 NHS Blood and Transplant Blood Banking and Blood Products Introduction
11.6.4 NHS Blood and Transplant Revenue in Blood Banking and Blood Products Business (2021–2026)
11.6.5 NHS Blood and Transplant Recent Development
11.7 New York Blood Center
11.7.1 New York Blood Center Company Details
11.7.2 New York Blood Center Business Overview
11.7.3 New York Blood Center Blood Banking and Blood Products Introduction
11.7.4 New York Blood Center Revenue in Blood Banking and Blood Products Business (2021–2026)
11.7.5 New York Blood Center Recent Development
11.8 Canadian Blood Services
11.8.1 Canadian Blood Services Company Details
11.8.2 Canadian Blood Services Business Overview
11.8.3 Canadian Blood Services Blood Banking and Blood Products Introduction
11.8.4 Canadian Blood Services Revenue in Blood Banking and Blood Products Business (2021–2026)
11.8.5 Canadian Blood Services Recent Development
11.9 Sanquin Blood Supply Foundation
11.9.1 Sanquin Blood Supply Foundation Company Details
11.9.2 Sanquin Blood Supply Foundation Business Overview
11.9.3 Sanquin Blood Supply Foundation Blood Banking and Blood Products Introduction
11.9.4 Sanquin Blood Supply Foundation Revenue in Blood Banking and Blood Products Business (2021–2026)
11.9.5 Sanquin Blood Supply Foundation Recent Development
11.10 Blood Bank of Alaska
11.10.1 Blood Bank of Alaska Company Details
11.10.2 Blood Bank of Alaska Business Overview
11.10.3 Blood Bank of Alaska Blood Banking and Blood Products Introduction
11.10.4 Blood Bank of Alaska Revenue in Blood Banking and Blood Products Business (2021–2026)
11.10.5 Blood Bank of Alaska Recent Development
11.11 Vitalant
11.11.1 Vitalant Company Details
11.11.2 Vitalant Business Overview
11.11.3 Vitalant Blood Banking and Blood Products Introduction
11.11.4 Vitalant Revenue in Blood Banking and Blood Products Business (2021–2026)
11.11.5 Vitalant Recent Development
11.12 National Blood Transfusion Council
11.12.1 National Blood Transfusion Council Company Details
11.12.2 National Blood Transfusion Council Business Overview
11.12.3 National Blood Transfusion Council Blood Banking and Blood Products Introduction
11.12.4 National Blood Transfusion Council Revenue in Blood Banking and Blood Products Business (2021–2026)
11.12.5 National Blood Transfusion Council Recent Development
11.13 Takeda
11.13.1 Takeda Company Details
11.13.2 Takeda Business Overview
11.13.3 Takeda Blood Banking and Blood Products Introduction
11.13.4 Takeda Revenue in Blood Banking and Blood Products Business (2021–2026)
11.13.5 Takeda Recent Development
11.14 CSL
11.14.1 CSL Company Details
11.14.2 CSL Business Overview
11.14.3 CSL Blood Banking and Blood Products Introduction
11.14.4 CSL Revenue in Blood Banking and Blood Products Business (2021–2026)
11.14.5 CSL Recent Development
11.15 Grifols
11.15.1 Grifols Company Details
11.15.2 Grifols Business Overview
11.15.3 Grifols Blood Banking and Blood Products Introduction
11.15.4 Grifols Revenue in Blood Banking and Blood Products Business (2021–2026)
11.15.5 Grifols Recent Development
11.16 Octapharma
11.16.1 Octapharma Company Details
11.16.2 Octapharma Business Overview
11.16.3 Octapharma Blood Banking and Blood Products Introduction
11.16.4 Octapharma Revenue in Blood Banking and Blood Products Business (2021–2026)
11.16.5 Octapharma Recent Development
11.17 Kedrion
11.17.1 Kedrion Company Details
11.17.2 Kedrion Business Overview
11.17.3 Kedrion Blood Banking and Blood Products Introduction
11.17.4 Kedrion Revenue in Blood Banking and Blood Products Business (2021–2026)
11.17.5 Kedrion Recent Development
11.18 LFB Group
11.18.1 LFB Group Company Details
11.18.2 LFB Group Business Overview
11.18.3 LFB Group Blood Banking and Blood Products Introduction
11.18.4 LFB Group Revenue in Blood Banking and Blood Products Business (2021–2026)
11.18.5 LFB Group Recent Development
11.19 Biotest
11.19.1 Biotest Company Details
11.19.2 Biotest Business Overview
11.19.3 Biotest Blood Banking and Blood Products Introduction
11.19.4 Biotest Revenue in Blood Banking and Blood Products Business (2021–2026)
11.19.5 Biotest Recent Development
11.20 BPL
11.20.1 BPL Company Details
11.20.2 BPL Business Overview
11.20.3 BPL Blood Banking and Blood Products Introduction
11.20.4 BPL Revenue in Blood Banking and Blood Products Business (2021–2026)
11.20.5 BPL Recent Development
11.21 RAAS
11.21.1 RAAS Company Details
11.21.2 RAAS Business Overview
11.21.3 RAAS Blood Banking and Blood Products Introduction
11.21.4 RAAS Revenue in Blood Banking and Blood Products Business (2021–2026)
11.21.5 RAAS Recent Development
11.22 CBPO
11.22.1 CBPO Company Details
11.22.2 CBPO Business Overview
11.22.3 CBPO Blood Banking and Blood Products Introduction
11.22.4 CBPO Revenue in Blood Banking and Blood Products Business (2021–2026)
11.22.5 CBPO Recent Development
11.23 Hualan Bio
11.23.1 Hualan Bio Company Details
11.23.2 Hualan Bio Business Overview
11.23.3 Hualan Bio Blood Banking and Blood Products Introduction
11.23.4 Hualan Bio Revenue in Blood Banking and Blood Products Business (2021–2026)
11.23.5 Hualan Bio Recent Development
11.24 Tiantan Bio
11.24.1 Tiantan Bio Company Details
11.24.2 Tiantan Bio Business Overview
11.24.3 Tiantan Bio Blood Banking and Blood Products Introduction
11.24.4 Tiantan Bio Revenue in Blood Banking and Blood Products Business (2021–2026)
11.24.5 Tiantan Bio Recent Development
11.25 Shuanglin Bio
11.25.1 Shuanglin Bio Company Details
11.25.2 Shuanglin Bio Business Overview
11.25.3 Shuanglin Bio Blood Banking and Blood Products Introduction
11.25.4 Shuanglin Bio Revenue in Blood Banking and Blood Products Business (2021–2026)
11.25.5 Shuanglin Bio Recent Development
11.26 Boya Bio
11.26.1 Boya Bio Company Details
11.26.2 Boya Bio Business Overview
11.26.3 Boya Bio Blood Banking and Blood Products Introduction
11.26.4 Boya Bio Revenue in Blood Banking and Blood Products Business (2021–2026)
11.26.5 Boya Bio Recent Development
11.27 Yuanda Shuyang
11.27.1 Yuanda Shuyang Company Details
11.27.2 Yuanda Shuyang Business Overview
11.27.3 Yuanda Shuyang Blood Banking and Blood Products Introduction
11.27.4 Yuanda Shuyang Revenue in Blood Banking and Blood Products Business (2021–2026)
11.27.5 Yuanda Shuyang Recent Development
11.28 Weiguang Bio
11.28.1 Weiguang Bio Company Details
11.28.2 Weiguang Bio Business Overview
11.28.3 Weiguang Bio Blood Banking and Blood Products Introduction
11.28.4 Weiguang Bio Revenue in Blood Banking and Blood Products Business (2021–2026)
11.28.5 Weiguang Bio Recent Development
11.29 Nanyue Bio
11.29.1 Nanyue Bio Company Details
11.29.2 Nanyue Bio Business Overview
11.29.3 Nanyue Bio Blood Banking and Blood Products Introduction
11.29.4 Nanyue Bio Revenue in Blood Banking and Blood Products Business (2021–2026)
11.29.5 Nanyue Bio Recent Development
11.30 KM Biologics
11.30.1 KM Biologics Company Details
11.30.2 KM Biologics Business Overview
11.30.3 KM Biologics Blood Banking and Blood Products Introduction
11.30.4 KM Biologics Revenue in Blood Banking and Blood Products Business (2021–2026)
11.30.5 KM Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Blood Banking and Blood Products Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of RBCs
 Table 3. Key Players of Plts
 Table 4. Key Players of Plasma
 Table 5. Key Players of Whole Blood
 Table 6. Key Players of Plasma Fractionation Products
 Table 7. Global Blood Banking and Blood Products Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global Blood Banking and Blood Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 9. Global Blood Banking and Blood Products Market Size by Region (US$ Million), 2021–2026
 Table 10. Global Blood Banking and Blood Products Market Share by Region (2021–2026)
 Table 11. Global Blood Banking and Blood Products Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 12. Global Blood Banking and Blood Products Market Share by Region (2027–2032)
 Table 13. Blood Banking and Blood Products Market Trends
 Table 14. Blood Banking and Blood Products Market Drivers
 Table 15. Blood Banking and Blood Products Market Challenges
 Table 16. Blood Banking and Blood Products Market Restraints
 Table 17. Global Blood Banking and Blood Products Revenue by Players (US$ Million), 2021–2026
 Table 18. Global Blood Banking and Blood Products Market Share by Players (2021–2026)
 Table 19. Global Top Blood Banking and Blood Products Players by Tier (Tier 1, Tier 2, and Tier 3), based on Blood Banking and Blood Products Revenue, 2025
 Table 20. Ranking of Global Top Blood Banking and Blood Products Companies by Revenue (US$ Million) in 2025
 Table 21. Global 5 Largest Players Market Share by Blood Banking and Blood Products Revenue (CR5 and HHI), 2021–2026
 Table 22. Global Key Players of Blood Banking and Blood Products, Headquarters and Area Served
 Table 23. Global Key Players of Blood Banking and Blood Products, Products and Applications
 Table 24. Global Key Players of Blood Banking and Blood Products, Date of General Availability (GA)
 Table 25. Mergers and Acquisitions, Expansion Plans
 Table 26. Global Blood Banking and Blood Products Market Size by Type (US$ Million), 2021–2026
 Table 27. Global Blood Banking and Blood Products Revenue Market Share by Type (2021–2026)
 Table 28. Global Blood Banking and Blood Products Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 29. Global Blood Banking and Blood Products Revenue Market Share by Type (2027–2032)
 Table 30. Global Blood Banking and Blood Products Market Size by Application (US$ Million), 2021–2026
 Table 31. Global Blood Banking and Blood Products Revenue Market Share by Application (2021–2026)
 Table 32. Global Blood Banking and Blood Products Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 33. Global Blood Banking and Blood Products Revenue Market Share by Application (2027–2032)
 Table 34. North America Blood Banking and Blood Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. North America Blood Banking and Blood Products Market Size by Country (US$ Million), 2021–2026
 Table 36. North America Blood Banking and Blood Products Market Size by Country (US$ Million), 2027–2032
 Table 37. Europe Blood Banking and Blood Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Europe Blood Banking and Blood Products Market Size by Country (US$ Million), 2021–2026
 Table 39. Europe Blood Banking and Blood Products Market Size by Country (US$ Million), 2027–2032
 Table 40. Asia-Pacific Blood Banking and Blood Products Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Asia-Pacific Blood Banking and Blood Products Market Size by Region (US$ Million), 2021–2026
 Table 42. Asia-Pacific Blood Banking and Blood Products Market Size by Region (US$ Million), 2027–2032
 Table 43. Latin America Blood Banking and Blood Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Latin America Blood Banking and Blood Products Market Size by Country (US$ Million), 2021–2026
 Table 45. Latin America Blood Banking and Blood Products Market Size by Country (US$ Million), 2027–2032
 Table 46. Middle East & Africa Blood Banking and Blood Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 47. Middle East & Africa Blood Banking and Blood Products Market Size by Country (US$ Million), 2021–2026
 Table 48. Middle East & Africa Blood Banking and Blood Products Market Size by Country (US$ Million), 2027–2032
 Table 49. America’s Blood Centers Company Details
 Table 50. America’s Blood Centers Business Overview
 Table 51. America’s Blood Centers Blood Banking and Blood Products Product
 Table 52. America’s Blood Centers Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 53. America’s Blood Centers Recent Development
 Table 54. Japan Red Cross Society Company Details
 Table 55. Japan Red Cross Society Business Overview
 Table 56. Japan Red Cross Society Blood Banking and Blood Products Product
 Table 57. Japan Red Cross Society Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 58. Japan Red Cross Society Recent Development
 Table 59. American Red Cross Company Details
 Table 60. American Red Cross Business Overview
 Table 61. American Red Cross Blood Banking and Blood Products Product
 Table 62. American Red Cross Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 63. American Red Cross Recent Development
 Table 64. Australia Red Cross Company Details
 Table 65. Australia Red Cross Business Overview
 Table 66. Australia Red Cross Blood Banking and Blood Products Product
 Table 67. Australia Red Cross Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 68. Australia Red Cross Recent Development
 Table 69. Red Cross Society of China Company Details
 Table 70. Red Cross Society of China Business Overview
 Table 71. Red Cross Society of China Blood Banking and Blood Products Product
 Table 72. Red Cross Society of China Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 73. Red Cross Society of China Recent Development
 Table 74. NHS Blood and Transplant Company Details
 Table 75. NHS Blood and Transplant Business Overview
 Table 76. NHS Blood and Transplant Blood Banking and Blood Products Product
 Table 77. NHS Blood and Transplant Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 78. NHS Blood and Transplant Recent Development
 Table 79. New York Blood Center Company Details
 Table 80. New York Blood Center Business Overview
 Table 81. New York Blood Center Blood Banking and Blood Products Product
 Table 82. New York Blood Center Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 83. New York Blood Center Recent Development
 Table 84. Canadian Blood Services Company Details
 Table 85. Canadian Blood Services Business Overview
 Table 86. Canadian Blood Services Blood Banking and Blood Products Product
 Table 87. Canadian Blood Services Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 88. Canadian Blood Services Recent Development
 Table 89. Sanquin Blood Supply Foundation Company Details
 Table 90. Sanquin Blood Supply Foundation Business Overview
 Table 91. Sanquin Blood Supply Foundation Blood Banking and Blood Products Product
 Table 92. Sanquin Blood Supply Foundation Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 93. Sanquin Blood Supply Foundation Recent Development
 Table 94. Blood Bank of Alaska Company Details
 Table 95. Blood Bank of Alaska Business Overview
 Table 96. Blood Bank of Alaska Blood Banking and Blood Products Product
 Table 97. Blood Bank of Alaska Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 98. Blood Bank of Alaska Recent Development
 Table 99. Vitalant Company Details
 Table 100. Vitalant Business Overview
 Table 101. Vitalant Blood Banking and Blood Products Product
 Table 102. Vitalant Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 103. Vitalant Recent Development
 Table 104. National Blood Transfusion Council Company Details
 Table 105. National Blood Transfusion Council Business Overview
 Table 106. National Blood Transfusion Council Blood Banking and Blood Products Product
 Table 107. National Blood Transfusion Council Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 108. National Blood Transfusion Council Recent Development
 Table 109. Takeda Company Details
 Table 110. Takeda Business Overview
 Table 111. Takeda Blood Banking and Blood Products Product
 Table 112. Takeda Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 113. Takeda Recent Development
 Table 114. CSL Company Details
 Table 115. CSL Business Overview
 Table 116. CSL Blood Banking and Blood Products Product
 Table 117. CSL Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 118. CSL Recent Development
 Table 119. Grifols Company Details
 Table 120. Grifols Business Overview
 Table 121. Grifols Blood Banking and Blood Products Product
 Table 122. Grifols Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 123. Grifols Recent Development
 Table 124. Octapharma Company Details
 Table 125. Octapharma Business Overview
 Table 126. Octapharma Blood Banking and Blood Products Product
 Table 127. Octapharma Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 128. Octapharma Recent Development
 Table 129. Kedrion Company Details
 Table 130. Kedrion Business Overview
 Table 131. Kedrion Blood Banking and Blood Products Product
 Table 132. Kedrion Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 133. Kedrion Recent Development
 Table 134. LFB Group Company Details
 Table 135. LFB Group Business Overview
 Table 136. LFB Group Blood Banking and Blood Products Product
 Table 137. LFB Group Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 138. LFB Group Recent Development
 Table 139. Biotest Company Details
 Table 140. Biotest Business Overview
 Table 141. Biotest Blood Banking and Blood Products Product
 Table 142. Biotest Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 143. Biotest Recent Development
 Table 144. BPL Company Details
 Table 145. BPL Business Overview
 Table 146. BPL Blood Banking and Blood Products Product
 Table 147. BPL Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 148. BPL Recent Development
 Table 149. RAAS Company Details
 Table 150. RAAS Business Overview
 Table 151. RAAS Blood Banking and Blood Products Product
 Table 152. RAAS Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 153. RAAS Recent Development
 Table 154. CBPO Company Details
 Table 155. CBPO Business Overview
 Table 156. CBPO Blood Banking and Blood Products Product
 Table 157. CBPO Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 158. CBPO Recent Development
 Table 159. Hualan Bio Company Details
 Table 160. Hualan Bio Business Overview
 Table 161. Hualan Bio Blood Banking and Blood Products Product
 Table 162. Hualan Bio Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 163. Hualan Bio Recent Development
 Table 164. Tiantan Bio Company Details
 Table 165. Tiantan Bio Business Overview
 Table 166. Tiantan Bio Blood Banking and Blood Products Product
 Table 167. Tiantan Bio Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 168. Tiantan Bio Recent Development
 Table 169. Shuanglin Bio Company Details
 Table 170. Shuanglin Bio Business Overview
 Table 171. Shuanglin Bio Blood Banking and Blood Products Product
 Table 172. Shuanglin Bio Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 173. Shuanglin Bio Recent Development
 Table 174. Boya Bio Company Details
 Table 175. Boya Bio Business Overview
 Table 176. Boya Bio Blood Banking and Blood Products Product
 Table 177. Boya Bio Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 178. Boya Bio Recent Development
 Table 179. Yuanda Shuyang Company Details
 Table 180. Yuanda Shuyang Business Overview
 Table 181. Yuanda Shuyang Blood Banking and Blood Products Product
 Table 182. Yuanda Shuyang Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 183. Yuanda Shuyang Recent Development
 Table 184. Weiguang Bio Company Details
 Table 185. Weiguang Bio Business Overview
 Table 186. Weiguang Bio Blood Banking and Blood Products Product
 Table 187. Weiguang Bio Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 188. Weiguang Bio Recent Development
 Table 189. Nanyue Bio Company Details
 Table 190. Nanyue Bio Business Overview
 Table 191. Nanyue Bio Blood Banking and Blood Products Product
 Table 192. Nanyue Bio Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 193. Nanyue Bio Recent Development
 Table 194. KM Biologics Company Details
 Table 195. KM Biologics Business Overview
 Table 196. KM Biologics Blood Banking and Blood Products Product
 Table 197. KM Biologics Revenue in Blood Banking and Blood Products Business (US$ Million), 2021–2026
 Table 198. KM Biologics Recent Development
 Table 199. Research Programs/Design for This Report
 Table 200. Key Data Information from Secondary Sources
 Table 201. Key Data Information from Primary Sources
 Table 202. Authors List of This Report


List of Figures
 Figure 1. Blood Banking and Blood Products Picture
 Figure 2. Global Blood Banking and Blood Products Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Blood Banking and Blood Products Market Share by Type: 2025 vs 2032
 Figure 4. RBCs Features
 Figure 5. Plts Features
 Figure 6. Plasma Features
 Figure 7. Whole Blood Features
 Figure 8. Plasma Fractionation Products Features
 Figure 9. Global Blood Banking and Blood Products Market Size by Application (US$ Million), 2021–2032
 Figure 10. Global Blood Banking and Blood Products Market Share by Application: 2025 vs 2032
 Figure 11. Hospital Case Studies
 Figure 12. Clinic Case Studies
 Figure 13. Retail Pharmacy Case Studies
 Figure 14. Others Case Studies
 Figure 15. Blood Banking and Blood Products Report Years Considered
 Figure 16. Global Blood Banking and Blood Products Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 17. Global Blood Banking and Blood Products Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Blood Banking and Blood Products Market Share by Region: 2025 vs 2032
 Figure 19. Global Blood Banking and Blood Products Market Share by Players in 2025
 Figure 20. Global Blood Banking and Blood Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 21. The Top 10 and 5 Players Market Share by Blood Banking and Blood Products Revenue in 2025
 Figure 22. North America Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. North America Blood Banking and Blood Products Market Share by Country (2021–2032)
 Figure 24. United States Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Canada Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Europe Blood Banking and Blood Products Market Share by Country (2021–2032)
 Figure 28. Germany Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. France Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. U.K. Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Italy Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Russia Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Ireland Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Asia-Pacific Blood Banking and Blood Products Market Share by Region (2021–2032)
 Figure 36. China Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Japan Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. South Korea Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Southeast Asia Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. India Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Australia & New Zealand Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Latin America Blood Banking and Blood Products Market Share by Country (2021–2032)
 Figure 44. Mexico Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Brazil Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Middle East & Africa Blood Banking and Blood Products Market Share by Country (2021–2032)
 Figure 48. Israel Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Saudi Arabia Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. UAE Blood Banking and Blood Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. America’s Blood Centers Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 52. Japan Red Cross Society Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 53. American Red Cross Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 54. Australia Red Cross Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 55. Red Cross Society of China Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 56. NHS Blood and Transplant Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 57. New York Blood Center Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 58. Canadian Blood Services Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 59. Sanquin Blood Supply Foundation Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 60. Blood Bank of Alaska Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 61. Vitalant Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 62. National Blood Transfusion Council Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 63. Takeda Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 64. CSL Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 65. Grifols Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 66. Octapharma Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 67. Kedrion Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 68. LFB Group Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 69. Biotest Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 70. BPL Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 71. RAAS Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 72. CBPO Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 73. Hualan Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 74. Tiantan Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 75. Shuanglin Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 76. Boya Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 77. Yuanda Shuyang Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 78. Weiguang Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 79. Nanyue Bio Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 80. KM Biologics Revenue Growth Rate in Blood Banking and Blood Products Business (2021–2026)
 Figure 81. Bottom-up and Top-down Approaches for This Report
 Figure 82. Data Triangulation
 Figure 83. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS